

Equillium stock is trading higher Monday after the company announced up to $50 million in financing through a securities purchase agreement with investors to...
You can purchase shares of Equillium (NASDAQ:EQ) through any online brokerage.
Other companies in Equillium’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Equillium has a consensus price target of $8.71.
The stock price for Equillium (NASDAQ: EQ) is $1.3 last updated October 26, 2026 at 7:43 PM EDT.
There are no upcoming dividends for Equillium.
Equillium does not have any upcoming earnings scheduled.
There is no upcoming split for Equillium.
Equillium is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl...